TGA and APAC regulatory fluency - 20+ years across clinical translation, R&D strategy and commercialisation
Strategic differentiation. Rigorous evidence. Protected commercial value.
I work with ingredient manufacturers and nutraceutical companies as a fractional Chief Scientific & Innovation Officer - helping you conceptualise differentiated opportunities, design evidence that creates real advantage, and turn science into claims and commercial outcomes that hold up under scrutiny.
The Challenge
Most companies invest heavily in research and new product development yet still struggle to create meaningful differentiation or defensible commercial assets.
Clinical studies are commissioned in isolation. Claims lack strategic architecture. Novel product, result, applications and cross-category opportunities are missed.
The outcome? Promising ingredients and products that never achieve their full market or regulatory potential.
I help you fix this at the single product/study and also at strategic level.
Where I Create Value — Three Strategic Pillars
I help you see and shape opportunities others miss.
What this looks like
Innovation conceptualisation and out-of-box repositioning
Identification of novel applications, cross-category crossovers, and white-space opportunities
Point-of-difference strategy and claims architecture ideation
IP opportunity mapping and differentiation pathways
Strategic brainstorming to unlock new value from existing or under-leveraged ingredients and R&D prioritisation
Outcome
Clear, ownable directions that create genuine competitive separation rather than incremental “me-too” positioning.
I design and oversee evidence programs that move the needle commercially and regulatorily.
What this looks like
Evidence gap analysis and multi-year clinical development roadmaps
Clinical trial architecture with built-in failure-risk mitigation (so studies remain valuable even if primary endpoints disappoint)
Endpoint, biomarker, and population strategy aligned to both regulatory and marketing goals
Scientific oversight, CSR review & interpretation, and publication planning
Claims substantiation, regulatory evidence packages, and vulnerability assessment
Outcome
Evidence that supports stronger, more defensible claims and creates lasting commercial assets - not just data points.
End-to-end bridging of science, regulation, and market adoption.
What this looks like
Comprehensive scientific dossiers and ingredient monographs
Marketing science support — translating complex data into clear, credible narratives for distributors, practitioners, and sales teams
KOL identification, advisory programs, and practitioner adoption strategies
Strategic partnership development and cross-industry collaboration opportunities
Ongoing fractional Chief Scientific & Innovation Officer leadership
Outcome
Science that travels successfully from your facility or supplier network into regulatory submissions, commercial materials, and real-world adoption.
You get one strategic partner who sees the full picture, rather than a collection of siloed consultants. This integrated approach maximises ROI on your scientific investments and creates lasting competitive advantage.
Your partner throughout the whole lifecycle
Engagement Models
Choose the level of partnership that best fits your current needs and growth stage. All engagements begin with a focused Strategy Conversation.
Targeted support for specific needs
Examples: Evidence Gap Analysis, Innovation Workshop, Claims Review, Scientific Dossier
Ideal for: One-off challenges or defined deliverables
Ongoing strategic guidance (monthly/quarterly)
Prioritisation, oversight, and decision support
Ideal for: Regular innovation pipeline and evidence strategy input
Embedded senior leadership (typically 1-2 days/week)
Full-spectrum scientific & commercial governance
Ideal for: Companies wanting consistent high-level strategic direction without a full-time hire